Genentech Names Henner as Head of Research; After Fifteen Years Helping to Build What is Arguably the Biotechnology Industry's Most Formidable Research Organization, Henner Assumes the Helm.SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BUSINESS WIRE)--April 29, 1996-- Genentech, Inc. (NYSE NYSE See: New York Stock Exchange : GNE GNE Gateway Network Element (data communications) GNE Game Neverending (MMORPG) GNE Gross National Expenditure GNE Game Networking Engine GNE Graphical Network Editor (Nortel) ) today announced the appointment of Dennis Henner as Vice President of Research and a member of its Operations Committee. The post, previously headed by Genentech President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Arthur Levinson, oversees what many see as the most prolific research organization in the biotechnology industry. Henner had been serving as Acting Vice President of Research since Levinson's appointment as president and CEO. "Dennis Henner has been instrumental in leading the strategic direction and scientific productivity at Genentech," said Arthur Levinson. "Dennis has strong qualifications in terms of scientific credentials, management capability, and understanding of our research culture and our scientific staff," added Levinson. Henner joined Genentech in 1981 as a scientist in the Molecular Biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller department after completing his Ph.D. in Microbiology at the University of Virginia Medical School and his postdoctoral fellowship at Scripps Clinic & Research Foundation. He was promoted to Director of Cell Genetics in 1986, became a Staff Scientist in 1990, and was appointed Vice President of Research Technology in 1994. He has published more than 60 papers in peer-reviewed scientific journals or books. Genentech is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Ten of the currently marketed biotechnology products stem from Genentech research, five of which Genentech markets directly. The company has headquarters in South San Francisco, California South San Francisco is a city in San Mateo County, California, United States, located on the San Francisco Peninsula in the San Francisco Bay Area. The population was 60,552 at the 2000 census. , and is traded on the New York and Pacific Stock Exchanges under the symbol GNE. Genentech's World Wide Web address is http://www.gene.com. CONTACT: Genentech Inc. Laura Leber, 415/225-5759 Lisa Brock, 415/225-1034 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion